A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

NCT05258266 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ZX-101A

Sponsor

Nanjing Zenshine Pharmaceuticals